Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Seres Therapeutics, Inc. | Executive Vice President, Chief People Officer | Common Stock | 45.7K | $61.7K | $1.35 | Oct 30, 2023 | Direct |
Seres Therapeutics, Inc. | Executive Vice President, Chief People Officer | Restricted Stock Units | 9.42K | $10.2K | $1.08 | Oct 27, 2023 | Direct |
Seres Therapeutics, Inc. | Executive Vice President, Chief People Officer | Stock Option (Right to Buy) | 95K | Feb 3, 2023 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
MCRB | Seres Therapeutics, Inc. | Oct 27, 2023 | 4 | -$3.92K | 4 | Oct 31, 2023 | Executive Vice President, Chief People Officer |
MCRB | Seres Therapeutics, Inc. | Feb 3, 2023 | 2 | $0 | 4 | Feb 7, 2023 | Executive Vice President, Chief People Officer |
MCRB | Seres Therapeutics, Inc. | Jul 5, 2022 | 1 | $100K | 4 | Jul 6, 2022 | Executive Vice President, Chief People Officer |
MCRB | Seres Therapeutics, Inc. | Feb 7, 2022 | 1 | $0 | 4 | Feb 8, 2022 | Executive Vice President, Chief People Officer |
MCRB | Seres Therapeutics, Inc. | Feb 7, 2022 | 0 | $0 | 3 | Feb 8, 2022 | Executive Vice President, Chief People Officer Exhibit List: Exhibit 24 - Power of Attorney |